The conference Mobile Pharma World, Europe was held last year in Amsterdam. I was given the honor to chair the conference. Here are my statements to open the conference and to conclude them. Do you think that pharma has made the big leap yet, now in 2013?

In an era of increasing diversification of print, broadcast and online media outlets, how can life sciences companies maximise the efficiency and impact of their communications channels?
What specific strategies should life sciences companies employ to ensure they get the maximum benefit from digital communications channels such as social networking sites and blogs?

In the Dutch pharmaceutical market several developments have influenced prescription policies of GPs. The liberalization of the health care market in the Netherlands has led the health care insurance companies to challenge GPs on their policies on treatment of chronic conditions.
These health care groups¹ went also on to develop prescription policies, endorsed to do so by extra reimbursement schemes from the part of the insurance companies.
In an early stage, we have acknowledged the potential impact of these health care groups on actual prescription routines. With the pharmaceutical company that we worked with, we configured an account team that would focus specifically on these groups.